Back

Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolemia phenotype

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Lipid management and outcome Lipid-Lowering Agents ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Epameinondas Fountas

Euroclinic of Athens, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Impact of statin therapy on long-term clinical outcomes between STEMI and NSTEMI after stent implantation
Professor A. Her (Chuncheon, KR)
Abstract
Presentation thumbnail
Adherence to statin therapy drives survival of patients with symptomatic peripheral artery disease
Assistant Professor J. Dopheide (Thun, CH)
Abstract Slides
Presentation thumbnail
Safety profile of bempedoic acid: pooled analysis of 4 phase 3 clinical trials
Doctor C. Ballantyne (Houston, US)
Abstract Slides
Presentation thumbnail
Eicosapentaenoic acid therapy is associated with decreased coronary plaque instability assessed using optical frequency domain imaging
Doctor T. Konishi (Sapporo, JP)
Abstract Slides
Presentation thumbnail
Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials
Doctor P. Guedeney (Paris, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Lipid management and outcome

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Where are we now? Decision-making in LDL-C lowering and CV risk
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
New trial evidence in the field of lipid management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources